Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers

Hiroshi Nishihara1, Shinya Tanaka, Masumi Tsuda

  • 1Laboratory of Molecular and Cellular Pathology, Hokkaido University School of Medicine, N 15, W7, Kita-ku, Sapporo, Japan.

Cancer Letters
|March 26, 2002
PubMed

Insights

The signaling adaptor protein Crk (also known as c-Crk-II) showed no genomic mutations but was significantly elevated in human cancers, correlating with cell growth rates.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Crk is a signaling adaptor protein with SH2 and SH3 domains, crucial for cell proliferation, differentiation, and migration.
  • v-Crk, an oncoprotein, was initially isolated from an avian sarcoma virus, prompting investigation into c-Crk's role in human cancers.

Purpose of the Study:

  • To investigate the potential role of c-Crk in human cancer development.
  • To analyze gene mutations and expression levels of c-Crk in various human cancers.

Main Methods:

  • Human bacterial artificial chromosome cloning to analyze Crk genome and exon/intron structures.
  • Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) to detect genomic mutations.
  • Immunohistochemical analysis of c-Crk-II expression in tumor tissues.
  • Immunoblot analysis of c-Crk-II in human lung cancer cell lines.

Main Results:

  • No genomic mutations in Crk exons were found to be related to carcinogenesis.
  • Significantly elevated levels of c-Crk-II were observed in most human tumors, especially colon and lung cancers.
  • In human lung cancer cell lines, c-Crk-II expression levels correlated positively with cell growth rates.

Conclusions:

  • Elevated expression of c-Crk-II, rather than genomic mutations, may be associated with the development of human cancers.
  • c-Crk-II is a potential biomarker and therapeutic target in oncology.
  • Further research is warranted to elucidate the precise mechanisms by which c-Crk-II contributes to carcinogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...